Literature DB >> 18725205

Caveolin-1 regulates BMPRII localization and signaling in vascular smooth muscle cells.

Jeffrey W Wertz1, Philip M Bauer.   

Abstract

Recent studies demonstrate the interaction of BMPRII and caveolin-1 in various cell types. In this study we test the hypothesis that caveolin-1 interacts with and regulates BMPRII-dependent signaling in vascular smooth muscle cells. We demonstrate that BMPRII localizes to caveolae and directly interacts with caveolin-1 in mouse aortic smooth muscle cells. We demonstrate that this interaction is mediated by the caveolin-1 scaffolding domain and is regulated by caveolin-1 phosphorylation. Downregulation of caveolin-1 via siRNA resulted in a loss of BMP-dependent SMAD phosphorylation and gene regulation. Further studies revealed that loss of caveolin-1 results in decreased BMPRII membrane localization and decreased association of BMPRII with the type I BMP receptor BMPRIa. Dominant negative caveolin-1 decreased BMPRII membrane localization suggesting a role for caveolin-1 in BMPRII trafficking. Taken together, our findings establish caveolin-1 as an important regulator of downstream signaling and membrane targeting of BMPRII in vascular smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18725205     DOI: 10.1016/j.bbrc.2008.08.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  Initiation of BMP2 signaling in domains on the plasma membrane.

Authors:  Jeremy Bonor; Elizabeth L Adams; Beth Bragdon; Oleksandra Moseychuk; Kirk J Czymmek; Anja Nohe
Journal:  J Cell Physiol       Date:  2012-07       Impact factor: 6.384

2.  Neogenin regulation of BMP-induced canonical Smad signaling and endochondral bone formation.

Authors:  Zheng Zhou; Jianxin Xie; Daehoon Lee; Yu Liu; Jiung Jung; Lijuan Zhou; Shan Xiong; Lin Mei; Wen-Cheng Xiong
Journal:  Dev Cell       Date:  2010-07-20       Impact factor: 12.270

3.  Abnormal expression of NSF, α-SNAP and SNAP23 in pulmonary arterial hypertension in rats treated with monocrotaline.

Authors:  Hong-Liang Zhang; Zhi-Hong Liu; Qin Luo; Yong Wang; Zhi-Hui Zhao
Journal:  Int J Clin Exp Med       Date:  2015-02-15

Review 4.  The role of genetics in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

5.  Inflammation-induced caveolin-1 and BMPRII depletion promotes endothelial dysfunction and TGF-β-driven pulmonary vascular remodeling.

Authors:  Suellen D S Oliveira; Maricela Castellon; Jiwang Chen; Marcelo G Bonini; Xiaowu Gu; Michael H Elliott; Roberto F Machado; Richard D Minshall
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-02-10       Impact factor: 5.464

6.  Elafin Reverses Pulmonary Hypertension via Caveolin-1-Dependent Bone Morphogenetic Protein Signaling.

Authors:  Nils P Nickel; Edda Spiekerkoetter; Mingxia Gu; Caiyun G Li; Hai Li; Mark Kaschwich; Isabel Diebold; Jan K Hennigs; Ki-Yoon Kim; Kazuya Miyagawa; Lingli Wang; Aiqin Cao; Silin Sa; Xinguo Jiang; Raymond W Stockstill; Mark R Nicolls; Roham T Zamanian; Richard D Bland; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-06-01       Impact factor: 21.405

7.  Rescuing BMPR2-driven endothelial dysfunction in PAH: a novel treatment strategy for the future?

Authors:  Rozenn Quarck; Fréderic Perros
Journal:  Stem Cell Investig       Date:  2017-06-14

8.  Bone morphogenetic protein receptor II is a novel mediator of endothelial nitric-oxide synthase activation.

Authors:  Archana Gangopahyay; Max Oran; Eileen M Bauer; Jeffrey W Wertz; Suzy A Comhair; Serpil C Erzurum; Philip M Bauer
Journal:  J Biol Chem       Date:  2011-08-01       Impact factor: 5.157

9.  Real-time dynamic movement of caveolin-1 during smooth muscle contraction of human colon and aged rat colon transfected with caveolin-1 cDNA.

Authors:  Sita Somara; Daniela Bashllari; Robert R Gilmont; Khalil N Bitar
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-03-03       Impact factor: 4.052

10.  Heritable forms of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Semin Respir Crit Care Med       Date:  2013-09-13       Impact factor: 3.119

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.